David Herold
Papers
1
Total Citations
7
H-Index
1
About
David Herold is a radiation oncologist whose research focuses on optimizing treatment outcomes and quality of life for prostate cancer patients, particularly through the use of stereotactic body radiation therapy (SBRT). His most-cited work, a 2013 study on patient-reported quality of life in intermediate-risk prostate cancer patients treated with SBRT, has garnered 7 citations and represents a key contribution to the field. This research helped establish that SBRT, while offering a highly precise and shortened treatment course, does not compromise patients’ perceived well-being—a critical insight for shared decision-making. Herold’s work bridges the gap between clinical efficacy and patient-centered care, emphasizing that treatment success must be measured not only by disease control but also by the preservation of function and daily living. His findings have informed clinical guidelines and encouraged broader adoption of SBRT as a standard option for intermediate-risk disease. By prioritizing patient-reported outcomes, Herold has advanced a more holistic approach to prostate cancer management, ensuring that technological innovations in radiation therapy translate into meaningful benefits for those undergoing treatment.
Research Focus
Key Achievements
Top Papers
- 1